7Baggers

Theravance Biopharma Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Operating Cashflow  
 Investing Cashflow  
 Financing Cashflow  
 Capital Expenditure  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -0.72-0.47-0.210.050.310.560.821.08Billion

Theravance Biopharma Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
  net cash from operating activities-854,000 -2,486,000 -12,436,000 -11,221,000 -124,055,000 -22,137,000 -14,730,000 -26,069,000 -42,434,000 -45,446,000 -50,113,000 -69,865,000 -64,925,000 -77,031,000 -53,346,000 -55,101,000 -64,352,000 -44,622,000 -48,030,000 -81,193,000 
  net cash from investing activities-677,000 -21,000 11,047,000 -43,046,000 39,161,000 1,075,409,000 7,515,000 31,924,000 10,824,000 -35,793,000 35,766,000 113,697,000 52,368,000 66,539,000 -176,589,000 68,403,000 14,061,000 -23,656,000 -1,296,000 -72,160,000 
  net cash from financing activities-30,609,000 -31,404,000 -80,680,000 -56,240,000 -35,472,000 -722,026,000 140,000 -1,448,000 149,000 -2,286,000 105,285,000 -11,288,000 743,000 -963,000 1,873,000 261,432,000 -1,544,000 -134,000 4,402,000 -1,433,000 
  capital expenditure-677,000 -21,000 -852,000 -938,000 -266,000 57,000 -113,000 -250,000 -444,000 -1,039,000 -156,000 -1,767,000 -1,244,000 -2,050,000 -2,368,000 -954,000 -1,303,000 -77,000 -576,000 -1,220,000 

We provide you with 20 years of cash flow statements for Theravance Biopharma stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Theravance Biopharma stock. Explore the full financial landscape of Theravance Biopharma stock with our expertly curated income statements.

The information provided in this report about Theravance Biopharma stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.